Scholl J M, Veau P, Benacerraf A, Brau J, Hennetier G, Achard F
Centre Cardiologique du Nord, Saint-Denis, France.
Am Heart J. 1988 Mar;115(3):559-64. doi: 10.1016/0002-8703(88)90804-6.
The clinical course of 48 consecutive patients with vasospastic angina and minor coronary atherosclerosis (no stenoses greater than 50%) was analyzed during an average follow-up period of 47 months. The study group consisted of 37 men and 11 women. Patients were treated with usual doses of calcium antagonists. One patient died (2%) and three had myocardial infarctions (6%). Seventy-one percent were asymptomatic or had infrequent angina; 13% had recurrences but had periods of remission lasting at least 10 months. Only 16% had persistent angina. None of the clinical or angiographic findings at the time of diagnosis were predictive of myocardial infarction or death, and they could not separate angina-free patients from those with recurrences. Thus, vasospastic angina without fixed coronary narrowing has a good prognosis despite the possibility of recurrences. However, there is a slight risk of myocardial infarction and death. This fact should be considered if there are plans to discontinue treatment.
对48例连续性血管痉挛性心绞痛且伴有轻度冠状动脉粥样硬化(狭窄不超过50%)的患者在平均47个月的随访期内的临床病程进行了分析。研究组包括37名男性和11名女性。患者接受常规剂量的钙拮抗剂治疗。1例患者死亡(2%),3例发生心肌梗死(6%)。71%的患者无症状或心绞痛发作不频繁;13%的患者有复发,但有至少持续10个月的缓解期。只有16%的患者有持续性心绞痛。诊断时的临床或血管造影结果均不能预测心肌梗死或死亡,也无法将无心绞痛患者与复发患者区分开来。因此,无固定冠状动脉狭窄的血管痉挛性心绞痛尽管有复发的可能,但预后良好。然而,存在轻微的心肌梗死和死亡风险。如果有停药计划,应考虑这一事实。